Literature DB >> 6594239

Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents.

H Haas, R Zubi, T G Sacks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594239     DOI: 10.1007/bf02017382

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Purification and properties of -lactamase of pseudomonas aeruginosa.

Authors:  N Zyk; A Kalkstein; N Citri
Journal:  Isr J Med Sci       Date:  1972-12

2.  In vitro susceptibility of Mycobacterium fortuitum, M. abscessus and M. borstelense to vancomycin.

Authors:  J Michel; H Haas; T G Sacks
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

3.  In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.

Authors:  M H Cynamon; G S Palmer
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

4.  In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.

Authors:  H Haas; J Michel; T G Sacks
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

  4 in total
  4 in total

1.  Imipenem/cilastatin.

Authors:  M Barza
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 2.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 3.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

4.  Urinary Mycobacterium fortuitum infection.

Authors:  B Oren; R Raz; H Hass
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.